These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma. Case report. Albuquerque FC, Hinton DR, Weiss MH. J Neurosurg; 1998 Dec; 89(6):1043-6. PubMed ID: 9833836 [Abstract] [Full Text] [Related]
8. Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine. Thorner MO, Evans WS, MacLeod RM, Nunley WC, Rogol AD, Morris JL, Besser GM. Adv Biochem Psychopharmacol; 1980 Dec; 23():165-89. PubMed ID: 7395611 [No Abstract] [Full Text] [Related]
9. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A. J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830 [Abstract] [Full Text] [Related]
10. Outcome of treatment with bromocriptine in patients with hyperprolactinaemia. al-Suleiman SA, Najashi S, Rahman J, Rahman MS. Aust N Z J Obstet Gynaecol; 1989 May; 29(2):176-9. PubMed ID: 2803131 [Abstract] [Full Text] [Related]
11. Continuous bromocriptine treatment of empty sella syndrome aggravating pregnancy. A case report. Georgiev DB, Dokumov SI. Gynecol Obstet Invest; 1991 May; 32(4):243-4. PubMed ID: 1778518 [Abstract] [Full Text] [Related]
12. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction. Yuen BH. Int J Fertil; 1986 May; 31(1):67-70. PubMed ID: 2908279 [Abstract] [Full Text] [Related]
13. Macroprolactinemia and Empty Sella Syndrome. Taieb A, Maha KN, El Abed YH, Beizig AM, Chadli MC, Ach K. Pan Afr Med J; 2017 May; 27():278. PubMed ID: 29187947 [Abstract] [Full Text] [Related]
14. [Hyperprolactinemia]. Müller OA, von Werder K. Z Arztl Fortbild (Jena); 1991 Feb 25; 85(3-4):125-30. PubMed ID: 1676201 [No Abstract] [Full Text] [Related]
15. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T. J Clin Endocrinol Metab; 2010 Jun 25; 95(6):2672-9. PubMed ID: 20357175 [Abstract] [Full Text] [Related]
16. Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma. Seki K, Kato K, Shima K. J Clin Endocrinol Metab; 1986 Apr 25; 62(4):783-4. PubMed ID: 3512593 [Abstract] [Full Text] [Related]
17. Experiences with the treatment of clinical hyperprolactinaemia. Nagy P, Szilágyi A, Csaba IF. Zentralbl Gynakol; 1987 Apr 25; 109(12):788-94. PubMed ID: 3630462 [Abstract] [Full Text] [Related]
18. High prolactin level. Piketty ML, Nataf F, Dilouya A, Roux FX. J Neurosurg; 2000 Feb 25; 92(2):368-9. PubMed ID: 10659034 [No Abstract] [Full Text] [Related]
20. Validation of the role of bromocriptine in the primary treatment of prolactinomas. Lamberts SW. Neth J Med; 1988 Apr 25; 32(3-4):107-11. PubMed ID: 3362264 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]